Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym

NCT06760156 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Large B-cell Lymphoma

Interventions

DRUG: Tafasitamab
DRUG: Lenalidomide

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]